2,3-bis(4-hydroxyphenyl)-propionitrile and vorinostat

2,3-bis(4-hydroxyphenyl)-propionitrile has been researched along with vorinostat in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ghanem, H; Helmy, MW; Omran, GA; Salahuddin, A	1

Other Studies

1 other study(ies) available for 2,3-bis(4-hydroxyphenyl)-propionitrile and vorinostat

Article	Year
Epigenetic restoration and activation of ERβ: an inspiring approach for treatment of triple-negative breast cancer. Medical oncology (Northwood, London, England), 2022, Jul-18, Volume: 39, Issue:10 Topics: Caspase 3; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Decitabine; Epigenesis, Genetic; Estrogen Receptor alpha; Estrogen Receptor beta; Humans; Insulin-Like Growth Factor I; Nitriles; Propionates; Triple Negative Breast Neoplasms; Vascular Endothelial Growth Factor A; Vorinostat	2022

Article

Year

Epigenetic restoration and activation of ERβ: an inspiring approach for treatment of triple-negative breast cancer.

Medical oncology (Northwood, London, England), 2022, Jul-18, Volume: 39, Issue:10

Topics: Caspase 3; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Decitabine; Epigenesis, Genetic; Estrogen Receptor alpha; Estrogen Receptor beta; Humans; Insulin-Like Growth Factor I; Nitriles; Propionates; Triple Negative Breast Neoplasms; Vascular Endothelial Growth Factor A; Vorinostat

2022